Hologic Stock - weekly sector review and peer comparison
19.06.2026 - 16:00:05 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:58 UTC. Details in the imprint.
Hologic (US4364401012) focuses this Friday on its positioning within the broader medical technology and diagnostics universe. With no fresh company-specific headlines from major wires or investor relations, the spotlight shifts to how the stock stacks up against sector peers over the week.
All news and analysis on Hologic stock
Track prior earnings, guidance comments and sector moves around Hologic stock on the dedicated topic page and via the company’s investor relations hub.
How Hologic fits its peer group
Hologic is best known as a women’s health and diagnostics specialist, sitting between large diversified medtech names and pure-play diagnostics groups in Standard & Poor’s 500 index sector classifications.
The company competes and collaborates with firms like BD, Abbott and GE HealthCare across screening, imaging and laboratory testing, often targeting similar hospital and lab budgets but with a tighter focus on women’s health pathways.
Weekly review across medical technology
This week, broader US healthcare and medtech benchmarks showed mixed trading as investors weighed interest-rate expectations against defensive sector characteristics, leaving diagnostics and imaging stocks generally rangebound.
Within that context, Hologic shares largely tracked the muted sector drift, without an identifiable catalyst from earnings, regulatory decisions or major M&A involving the company.
The product behind the stock
Hologic generates most of its revenue from diagnostic assays and breast and skeletal health imaging systems, including its widely deployed 3D mammography platform for breast cancer screening.
Where the stock trades today
Hologic shares (US4364401012) trade on Nasdaq at $77.14 as of 06/19/2026, 13:30 UTC.
Key facts on Hologic stock
- Company: Hologic Inc.
- ISIN: US4364401012
- WKN: 884330
- Ticker: HOLX
- Venue: Nasdaq
- Price (as of 06/19/2026, 13:30 UTC): 77.14 USD
- Market cap: 18,500,000,000 USD (as of 06/19/2026)
- Sector / Industry: Health Care - Medical Devices & Diagnostics
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
